News

GlaxoSmithKline (GSK) has issued a statement in response to the FDA’s Early Communication about the safety review of orlistat. The company said that the FDA is reviewing data

APP Pharmaceuticals (APP) has received approval from the FDA to market Penicillin G Potassium for Injection, USP, in two dosage strengths. Penicillin G is used to treat a

Karo Bio has reported that in the beginning of September 2009, Wyeth will take on all future research and development activities under the drug discovery collaboration between the

GeneThera has reported a major expansion of its previously reported efforts to commercialize a diagnostic platform for Johne’s disease. The company said that it is preparing to enter

Data published in The Journal of Bone and Joint Surgery demonstrates that use of ChloraPrep is more effective than both DuraPrep and povidone-iodine, at eliminating overall bacteria from

Protalix has received Fast Track Designation from the FDA for prGCD, the company’s proprietary plant-cell expressed recombinant form of glucocerebrosidase (GCD). It is intended for the treatment of

Resverlogix has released several quarterly updates for RVX-208, as apotential treatment of atherosclerosis and cardiovascular disease. The company claims that the phase 1b/2a study testing RVX-208 for 28

Myriad Genetics has reported an increase in molecular diagnostic revenue by 47% to $326.5m for fiscal year ended June 30, 2009, compared to $222.9m for the fiscal year

CardioDx, a cardiovascular genomic diagnostics company, has completed its multicenter validation study for Corus CAD. It is a gene expression test to quantify the likelihood of obstructive coronary